Roberta Luzzi
Impact in
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Medicinal Plants and Neuroprotection 6
-
- Venous Thromboembolism Diagnosis and Management 4
- Co-authors
- Mark Dugall (58 shared papers)Beatrice Feragalli (37 shared papers)Gianni V. Belcaro (24 shared papers)Umberto Cornelli (24 shared papers)Edmondo IPPOLITO (26 shared papers)Maria Rosaria Cesarone (29 shared papers)Masako Hosoi (18 shared papers)Antonio Ledda (18 shared papers)
- Journals
- Evidence-based Complementary and Alternative Medicine (1 paper)Planta Medica (1 paper)Blood (1 paper)Phytotherapy Research (1 paper)Phytomedicine (1 paper)
- Partner nations
- ItalyUnited StatesBrazil
In The Last Decade
Roberta Luzzi
63 papers receiving 670 citations
Peers
Comparison fields: 5 of 85
- Molecular Medicine 101
- Internal Medicine 52
- Biochemistry 91
- Complementary and alternative medicine 83
- Pharmacology 102
Countries citing papers authored by Roberta Luzzi
This map shows the geographic impact of Roberta Luzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Luzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Luzzi more than expected).
Fields of papers citing papers by Roberta Luzzi
This network shows the impact of papers produced by Roberta Luzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Luzzi. The network helps show where Roberta Luzzi may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberta Luzzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study. | 2011 | 88 |
| 2 | 1997 | 42 | |
| 3 | Meriva®, a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: a pilot, product evaluation registry study. | 2012 | 41 |
| 4 | 2013 | 34 | |
| 5 | 2018 | 27 | |
| 6 | TECA (Titrated Extract of Centella Asiatica): new microcirculatory, biomolecular, and vascular application in preventive and clinical medicine. A status paper. | 2011 | 26 |
| 7 | Pycnogenol® improvements in asthma management. | 2011 | 26 |
| 8 | 2014 | 24 | |
| 9 | Cranberry supplementation in the prevention of non-severe lower urinary tract infections: a pilot study. | 2015 | 22 |
| 10 | Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression. | 2015 | 18 |
| 11 | 2016 | 17 | |
| 12 | Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract. | 2016 | 17 |
| 13 | 2016 | 17 | |
| 14 | Improved management of primary chronic fatigue syndrome with the supplement French oak wood extract (Robuvit®): a pilot, registry evaluation. | 2014 | 16 |
| 15 | Pycnogenol® and Centella Asiatica for asymptomatic atherosclerosis progression. | 2014 | 15 |
| 16 | Effects of Pycnogenol® on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study. | 2015 | 15 |
| 17 | Topical formulation of heparin is effective in reducing the symptoms of superficial venous thrombosis: a monocenter, observer-blind, placebo-controlled randomized study. | 2011 | 15 |
| 18 | Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study. | 2011 | 13 |
| 19 | Bilberry extracts are not created equal: the role of non anthocyanin fraction. Discovering the "dark side of the force" in a preliminary study. | 2016 | 13 |
| 20 | Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35-55. | 2014 | 12 |
About Roberta Luzzi
Roberta Luzzi is a scholar working on Complementary and alternative medicine, Internal Medicine, Pharmacology, Rheumatology and Nutrition and Dietetics, having authored 64 papers that have together received 726 indexed citations. Recurring topics across this work include Medicinal Plants and Neuroprotection (6 papers), Pharmacological Effects of Medicinal Plants (5 papers), Diagnosis and Treatment of Venous Diseases (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Silymarin and Mushroom Poisoning (3 papers), Urinary Tract Infections Management (3 papers), Natural product bioactivities and synthesis (3 papers) and Urinary Bladder and Prostate Research (2 papers). The work is most often cited by research in Molecular Medicine (101 citations), Internal Medicine (52 citations), Biochemistry (91 citations), Complementary and alternative medicine (83 citations) and Pharmacology (102 citations). Roberta Luzzi has collaborated with scholars based in Italy, United States and Brazil. Frequent co-authors include Mark Dugall, Beatrice Feragalli, Gianni V. Belcaro, Umberto Cornelli, Edmondo IPPOLITO, Maria Rosaria Cesarone, Masako Hosoi, Antonio Ledda, Morio Hosoi and Gianni Belcaro. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, Planta Medica, Blood, Phytotherapy Research and Phytomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.